retatrutide parkinson's disease clinical trial retatrutide parkinson's disease trial Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update-150cent Parkinson's Disease Treatment The Emerging Role of GLP-1

10.1016/j.surg.2013.04.052 Surgery 150 ShibueK.YamaneS.HaradaN.HamasakiA.SuzukiK.JooE.et al (2015)

On top of that, rapid weight loss from GLP-1s can mess with your eustachian tube the small canal that links your middle ear to your throat leading to a feeling of fullness in the ears and contributing to sinus discomfort

Bullen, H

Potential side effects Like all medications that affect the digestive and metabolic systems, retatrutide may cause side effects, particularly when treatment begins

Micronutrient and Nutritional Deficiencies Associated With GLP 1 Receptor Agonist Therapy: A Narrative Review

As an important component of regulating metabolism and immune homeostasis, the vagus nerve can regulate WAT content through the central nervous system to control sympathetic peripheral muscle bundles, and can also regulate the release of GSH and NO to enhance antioxidant capacity and prevent ferroptosis (36)